Literature DB >> 16698119

In vitro antimicrobial activity of the novel polymeric guanidine Akacid plus.

C Kratzer1, S Tobudic, W Graninger, A Buxbaum, A Georgopoulos.   

Abstract

The bactericidal and fungicidal activity of Akacid plus, a novel polymeric compound of the cationic family of disinfectants, was compared with chlorhexidine digluconate using quality control strains of Staphylococcus aureus, Enterococcus hirae, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger. In vitro activity was determined using the quantitative suspension tests described by the European Committee for Standardization. These use concentrations of 0.01-0.5% against bacterial strains/C. albicans, with 0.5-4% against A. niger, and exposure times of 5, 15 and 60 min in the presence and absence of 0.3% bovine albumin and with dilution in distilled and hard water. In the basic quantitative suspension test, Akacid plus destroyed all bacterial pathogens at a concentration of 0.1% in < or =5 min. Chlorhexidine was also highly active against S. aureus, E. coli and P. aeruginosa, but failed to eliminate E. hirae within 5 min. A high organic load reduced the bactericidal activity of both disinfectants slightly. Akacid plus showed fungicidal activity against C. albicans within 15-60 min and eliminated A. niger at a concentration of 1% in 5 min of contact. Chlorhexidine was fungicidal against C. albicans, but not against A. niger.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698119     DOI: 10.1016/j.jhin.2006.01.024

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Validation of AKACID plus as a room disinfectant in the hospital setting.

Authors:  Christina Kratzer; Selma Tobudic; Ojan Assadian; Astrid Buxbaum; Wolfgang Graninger; Apostolos Georgopoulos
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Evaluation of the efficacy of akacid plus® fogging in eradicating causative microorganism in nosocomial infections.

Authors:  Nevzat Unal; Keramettin Yanik; Adil Karadag; Hakan Odabaşı; Saban Esen; Murat Günaydin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  In vivo activity of a novel polymeric guanidine in experimental skin infection with methicillin-resistant Staphylococcus aureus.

Authors:  Christina Kratzer; Selma Tobudic; Karin Macfelda; Wolfgang Graninger; Apostolos Georgopoulos
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

4.  The effect of polyhexamethylene guanidine hydrochloride (PHMG) derivatives introduced into polylactide (PLA) on the activity of bacterial enzymes.

Authors:  Maciej Walczak; Agnieszka Richert; Aleksandra Burkowska-But
Journal:  J Ind Microbiol Biotechnol       Date:  2014-09-05       Impact factor: 3.346

5.  Antimicrobial activity of polyhexamethylene guanidine phosphate in comparison to chlorhexidine using the quantitative suspension method.

Authors:  A Vitt; A Sofrata; V Slizen; R V Sugars; A Gustafsson; E I Gudkova; L A Kazeko; P Ramberg; K Buhlin
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-07-17       Impact factor: 3.944

6.  Antibacterial activity of THAM Trisphenylguanide against methicillin-resistant Staphylococcus aureus.

Authors:  Alan J Weaver; Joyce B Shepard; Royce A Wilkinson; Robert L Watkins; Sarah K Walton; Amanda R Radke; Thomas J Wright; Milat B Awel; Catherine Cooper; Elizabeth Erikson; Mohamed E Labib; Jovanka M Voyich; Martin Teintze
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

7.  Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivo.

Authors:  Hannes Neuwirt; Elisabeth Wabnig; Clemens Feistritzer; Iris E Eder; Christina Salvador; Martin Puhr; Zoran Culig; Petra Massoner; Martin Tiefenthaler; Michael Steurer; Guenther Konwalinka
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

8.  Sulfaguanidine Hybrid with Some New Pyridine-2-One Derivatives: Design, Synthesis, and Antimicrobial Activity against Multidrug-Resistant Bacteria as Dual DNA Gyrase and DHFR Inhibitors.

Authors:  Ahmed Ragab; Sawsan A Fouad; Ola A Abu Ali; Entsar M Ahmed; Abeer M Ali; Ahmed A Askar; Yousry A Ammar
Journal:  Antibiotics (Basel)       Date:  2021-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.